HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Naoko Ito Selected Research
Naoko Ito Research Topics
Disease
5
Multiple Sclerosis
01/2022 - 10/2008
4
Inflammation (Inflammations)
12/2023 - 01/2014
4
Neoplasms (Cancer)
08/2023 - 05/2007
3
Immunoglobulin G4-Related Disease
02/2024 - 01/2011
3
Type 2 Diabetes Mellitus (MODY)
01/2021 - 07/2011
3
Autoimmune Diseases (Autoimmune Disease)
12/2020 - 01/2014
2
Dysbiosis
01/2022 - 10/2017
2
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 01/2014
2
Relapsing-Remitting Multiple Sclerosis
02/2021 - 01/2014
2
Demyelinating Diseases (Demyelinating Disease)
02/2021 - 01/2014
2
Disease Progression
04/2016 - 01/2014
2
Chronic Renal Insufficiency
12/2014 - 08/2014
2
Anemia
08/2014 - 01/2009
2
Glucose Intolerance
01/2014 - 07/2011
2
Liver Cirrhosis (Hepatic Cirrhosis)
05/2013 - 01/2009
2
Wounds and Injuries (Trauma)
07/2006 - 03/2002
1
Membranous Glomerulonephritis (Membranous Nephropathy)
02/2024
1
Interstitial Nephritis (Tubulointerstitial Nephritis)
02/2024
1
Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
12/2023
1
Hypertrophy
12/2023
1
Mitochondrial encephalopathy
11/2023
1
MELAS Syndrome (Syndrome, MELAS)
11/2023
1
Lactic Acidosis
11/2023
1
Stroke (Strokes)
11/2023
1
Respiratory Insufficiency (Respiratory Failure)
08/2023
1
Body Weight (Weight, Body)
01/2021
1
Heart Failure
01/2021
1
Branchio-Oto-Renal Syndrome (Branchio Oculo Facial Syndrome)
05/2018
1
Hypoglycemia (Reactive Hypoglycemia)
01/2018
1
Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
08/2017
1
Glomerulonephritis
08/2017
1
Atypical Hemolytic Uremic Syndrome
04/2016
1
Pericardial Effusion
12/2015
1
Human Influenza (Influenza)
12/2015
1
Myocarditis (Carditis)
12/2015
1
Pericarditis
12/2015
1
Renal Tubular Acidosis (Distal Renal Tubular Acidosis)
11/2015
1
Hypokalemia
11/2015
1
Gallbladder Neoplasms (Gallbladder Cancer)
01/2015
1
Esophageal Neoplasms (Esophageal Cancer)
09/2014
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
09/2014
Drug/Important Bio-Agent (IBA)
4
Myelin Basic Protein
IBA
01/2022 - 10/2008
3
Immunoglobulin G (IgG)
IBA
02/2024 - 01/2011
3
Glucose (Dextrose)
FDA Link
Generic
01/2018 - 07/2011
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 05/2007
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2022 - 10/2017
2
Complement C3 (C3 Complement)
IBA
02/2021 - 10/2017
2
Darbepoetin alfa (Aranesp)
FDA Link
12/2014 - 08/2014
2
Triglycerides (Triacylglycerol)
IBA
01/2013 - 07/2011
2
jasmonic acid (jasmonate)
IBA
07/2006 - 03/2002
2
Protein Kinases (Protein Kinase)
IBA
07/2006 - 03/2002
1
nephrin
IBA
12/2023
1
Antibodies
IBA
12/2023
1
Creatinine
IBA
12/2023
1
Mitochondrial DNA (mtDNA)
IBA
11/2023
1
Synaptophysin
IBA
08/2023
1
Prednisolone (Predate)
FDA Link
Generic
08/2023
1
Chromogranin A
IBA
08/2023
1
Leukocyte L1 Antigen Complex (Calgranulin)
IBA
01/2022
1
Environmental Biomarkers
IBA
01/2022
1
Peptides (Polypeptides)
IBA
01/2022
1
Leukocyte Elastase (Neutrophil Elastase)
IBA
01/2022
1
Lipocalin-2
IBA
01/2022
1
Glatiramer Acetate (Copaxone)
FDA Link
07/2021
1
Dimethyl Fumarate
IBA
02/2021
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
01/2021
1
Liraglutide
FDA Link
01/2021
1
Glucagon-Like Peptide 1 (GLP 1)
IBA
01/2021
1
HLA Antigens (Human Leukocyte Antigens)
IBA
12/2020
1
Dichlororibofuranosylbenzimidazole (DRB)
IBA
12/2020
1
Epitopes
IBA
12/2020
1
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2018
1
Anaphylatoxins
IBA
10/2017
1
Autoantigens
IBA
10/2017
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
10/2017
1
Dichlorodiphenyldichloroethane (DDD)
IBA
08/2017
1
eculizumab
FDA Link
04/2016
1
Cytokines
IBA
12/2015
1
Zanamivir (Relenza)
FDA Link
12/2015
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2015
1
Interferons
IBA
12/2015
1
Interleukins
IBA
12/2015
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2015
1
Chemokines
IBA
12/2015
1
Neuraminidase (Sialidase)
IBA
12/2015
1
dirhodium tetraacetate (DRTA)
IBA
11/2015
1
Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)
IBA
11/2015
1
Chlorides
IBA
11/2015
1
Bicarbonates (Hydrogen Carbonate)
IBA
11/2015
1
ochratoxin A
IBA
01/2015
1
Aflatoxins
IBA
01/2015
1
Blood Glucose (Blood Sugar)
IBA
09/2014
Therapy/Procedure
6
Therapeutics
12/2015 - 05/2007
2
Hepatectomy
12/2013 - 10/2013
2
Drug Therapy (Chemotherapy)
11/2013 - 11/2011
1
Transplantation
12/2023
1
Ligation
05/2018
1
Glycemic Control
01/2018
1
Esophagectomy
09/2014
1
Laparotomy
09/2014